GLOBAL BIO-CHEM TECHNOLOGY GROUP COMPANY LIMITED Financials Global Bio-chem Technology Group Company Limited
Equities
809
KYG3919S1057
Food Processing
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.089 HKD | -1.11% |
|
-1.11% | -16.04% |
Valuation
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 774.3 | 313.6 | 1,152 | 3,340 | 1,105 | 1,390 |
| Enterprise Value (EV) 1 | 10,240 | 9,534 | 10,232 | 12,767 | 10,124 | 10,204 |
| P/E ratio | -0.92 x | -0.26 x | -0.96 x | -1.31 x | -2.76 x | -0.96 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 0.18 x | 0.06 x | 0.25 x | 3.93 x | 1.48 x | 3.73 x |
| EV / Revenue | 2.33 x | 1.69 x | 2.24 x | 15 x | 13.6 x | 27.4 x |
| EV / EBITDA | -99.6 x | -18.2 x | -50.5 x | -48.8 x | -16.8 x | -17.9 x |
| EV / FCF | -10.3 x | -368 x | 95.1 x | 28.7 x | -75.7 x | -273 x |
| FCF Yield | -9.7% | -0.27% | 1.05% | 3.49% | -1.32% | -0.37% |
| Price to Book | -0.32 x | -0.09 x | -0.27 x | -0.57 x | -0.17 x | -0.18 x |
| Nbr of stocks (in thousands) | 6,398,998 | 6,398,998 | 7,678,798 | 8,907,406 | 8,907,406 | 8,907,406 |
| Reference price 2 | 0.1210 | 0.0490 | 0.1500 | 0.3750 | 0.1240 | 0.1560 |
| Announcement Date | 4/30/18 | 4/17/19 | 4/28/20 | 4/23/21 | 5/12/22 | 4/24/23 |
1HKD in Million2HKD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 4,397 | 5,658 | 4,561 | 848.9 | 746.6 | 372.3 |
| EBITDA 1 | -102.9 | -524.7 | -202.4 | -261.6 | -604 | -569.5 |
| EBIT 1 | -500.5 | -1,005 | -681.8 | -693.3 | -982.3 | -877.9 |
| Operating Margin | -11.38% | -17.76% | -14.95% | -81.68% | -131.58% | -235.81% |
| Earnings before Tax (EBT) 1 | -1,049 | -1,367 | -1,077 | -2,411 | -409.5 | -1,574 |
| Net income 1 | -837.5 | -1,222 | -1,068 | -2,430 | -400.8 | -1,443 |
| Net margin | -19.05% | -21.6% | -23.41% | -286.26% | -53.69% | -387.63% |
| EPS 2 | -0.1309 | -0.1910 | -0.1555 | -0.2860 | -0.0450 | -0.1620 |
| Free Cash Flow 1 | -993.5 | -25.89 | 107.6 | 445.5 | -133.8 | -37.34 |
| FCF margin | -22.59% | -0.46% | 2.36% | 52.48% | -17.92% | -10.03% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 4/30/18 | 4/17/19 | 4/28/20 | 4/23/21 | 5/12/22 | 4/24/23 |
1HKD in Million2HKD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 9,466 | 9,221 | 9,081 | 9,426 | 9,019 | 8,815 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | -92.03 x | -17.57 x | -44.86 x | -36.04 x | -14.93 x | -15.48 x |
| Free Cash Flow 1 | -993 | -25.9 | 108 | 445 | -134 | -37.3 |
| ROE (net income / shareholders' equity) | 41.7% | 43% | 28.2% | 47% | 6.85% | 21% |
| ROA (Net income/ Total Assets) | -3.04% | -6.1% | -4.72% | -5.47% | -8.72% | -8.9% |
| Assets 1 | 27,571 | 20,031 | 22,629 | 44,403 | 4,597 | 16,218 |
| Book Value Per Share 2 | -0.3800 | -0.5400 | -0.5500 | -0.6600 | -0.7300 | -0.8500 |
| Cash Flow per Share 2 | 0.0500 | 0.0200 | 0.0100 | 0.0200 | 0 | 0 |
| Capex 1 | 336 | 145 | 51.4 | 16.8 | 25.8 | 6.18 |
| Capex / Sales | 7.63% | 2.55% | 1.13% | 1.98% | 3.46% | 1.66% |
| Announcement Date | 4/30/18 | 4/17/19 | 4/28/20 | 4/23/21 | 5/12/22 | 4/24/23 |
1HKD in Million2HKD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -16.04% | 101M | |
| -4.93% | 261B | |
| -2.51% | 94.98B | |
| +3.19% | 46.39B | |
| +8.74% | 39.99B | |
| -0.65% | 39.95B | |
| -0.15% | 38.02B | |
| -16.78% | 30.16B | |
| -6.61% | 28.72B | |
| +11.32% | 24.54B |
- Stock Market
- Equities
- 809 Stock
- Financials Global Bio-chem Technology Group Company Limited
